Akero Therapeutics Inc

Akero Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing transformational treatments for non-alcoholic steatohepatitis and other serious metabolic disorders. The company's product pipeline consists of AKR-001, for the treatment of non-alcoholic steatohepatitis, which are in clinical stage. Akero Therapeutics Inc. is based in San Francisco, United States.

Address Details

Address: 601 GATEWAY BOULEVARD SUITE 350

City: SOUTH SAN FRANCISCO

State: CA

Country: USA

Zip Code: 94080